Pneumococcal vaccine conjugate 10-valent (Panacea Biotech)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NamePneumococcal vaccine conjugate 10-valent (Panacea Biotech)

Drug Alias Name10-Valent pneumococcal polysaccharide conjugate vaccinePneumococcal 10-valent conjugate vaccine (adsorbed)Nucovac

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis APneumococcal InfectionsStreptococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPolandGermanyFrance +[5]

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPanacea

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsHepatitis APneumococcal InfectionsStreptococcal Infections

Other Information

ATC CodeN/A